Log in to your Inderes Free account to see all free content on this page.
Alzinova
3.5
SEK
+0.57 %
ALZ
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Be the first to follow this company
+0.57%
-3.31%
-8.38%
+196.61%
+42.38%
+37.62%
-16.75%
-51.3%
-51.2%
Alzinova is a biotechnology company. The company specializes in the therapeutic treatment of Alzheimer's and conducts research and development of peptides that are further developed as vaccines. In addition, the company also develops various research tools in the work area. The largest operations are in the Nordic market. The company was founded in 2011 and is headquartered in Gothenburg.
Read moreMarket cap
312.08M SEK
Turnover
898.53K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
27.2.
2025
Annual report '24
ShowingAll content types
Alzinova appoints Erik Kullgren as permanent CFO
Alzinova attends J.P. Morgan Healthcare Conference in San Francisco for meetings with industry partners and investors
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio